<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>4</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>04</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>NAD(P)H: Quinone Oxidoreductase 1 (NQO1) C609T Gene Polymorphism Association with Digestive Tract Cancer: A Meta-analysis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>2349</FirstPage>
			<LastPage>2354</LastPage>
			<ELocationID EIdType="pii">27641</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphisms have been reported to influence therisk for digestive tract cancer (DTC) in many studies; however, the results remain controversial and ambiguous.We therefore carried out a meta-analysis of published case-control studies to derive a more precise estimationof any associations. Electronic searches were conducted on links between this variant and DTC in severaldatabases through April 2012. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated toestimate the strength of associations in fixed or random effect models. Heterogeneity and publication bias werealso assessed. A total of 21 case-control studies were identified, including 6,198 cases and 7,583 controls. Overall,there was a statistically significant association between the NQO1 C609T polymorphism and DTC risk (TT vs.CC: OR=1.224, 95%CI=1.055-1.421; TT/CT vs. CC: OR=1.195, 95%CI=1.073-1.330; TT vs. CT/CC: OR=1.183,95%CI=1.029-1.359; T vs. C: OR=1.180, 95%CI=1.080-1.290). When stratified for tumor location, the resultsbased on all studies showed the variant allele 609T might have a significantly increased risk of upper digest tractcancer (UGIC), but not colorectal cancer. In the subgroup analysis by ethnicity, we observed a significantly riskfor DTC in Caucasians. For esophageal and gastric cancer, a significantly risk was found in both populations,and for colorectal, a weak risk was observed in Caucasians, but not Asians. This meta-analysis suggested thatthe NQO1 C609T polymorphism may increase the risk of DTC, especially in the upper gastric tract.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Digestive tract cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">NQO1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_27641_4426b411e0bca479b805038a4901f168.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
